Stock BTCY BIOTRICITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Biotricity, Inc.

Equities

BTCY

US09074H2031

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
1.35 USD -8.78% Intraday chart for Biotricity, Inc. +17.39% +17.39%
Apr. 19 Top Premarket Decliners MT
Apr. 09 Biotricity, Inc. announced that it has received $2 million in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Premarket Decliners
MT
Biotricity, Inc. announced that it has received $2 million in funding
CI
Biotricity announces a strategic partnership for cardiac screenings in patients with co-morbidities
AQ
Biotricity : Certificate of Incorporation/Bylaws - Form 8-K
PU
Biotricity Announces Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
CI
Biotricity, Inc. announced a financing transaction
CI
Biotricity Unveils That Improved Margins Resulted from Latest Advancements to Its Proprietary Cardiac Ai Cloud Platform and Announces Plans for Continued Expansion of Its Cardiac AI Cloud
CI
Biotricity, Inc. Solidifies It's Presence in the Healthcare Landscape
CI
Transcript : Biotricity, Inc., Q3 2024 Earnings Call, Feb 21, 2024
Biotricity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Biotricity Inc. Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 Billion Heartbeats
CI
HC Wainwright Downgrades Biotricity to Neutral From Buy
MT
Transcript : Biotricity, Inc., Q2 2024 Earnings Call, Nov 14, 2023
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Biotricity Releases Another Groundbreaking Product: Biotres Pro
CI
Biotricity Files Patent for Wearable Heart Monitoring Device Bioheart
MT
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
CI
Biotricity, Inc. Announces Patent Filing for Cutting-Edge Biotres Device
CI
Biotricity reports strong growth for its first quarter fiscal year 2024 and provides financial results and business updates
AQ
Transcript : Biotricity, Inc., Q1 2024 Earnings Call, Aug 15, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BTCY Stock
  4. News Biotricity, Inc.